Placing Legal Controls on Abortion Pills
In an opinion piece, News Team member Ellie Purinton argues that legal challenges to abortion-pill distribution threaten federal authority and pharmaceutical innovation.
The FDA Made a Mistake Approving This ALS Medication
New in the Opinion vertical: Andrew Feld delves into the FDA's controversial 2022 approval of the ALS drug Relyvrio.